Back to Search
Start Over
Cross‐reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH‐AH 01/2010 Study
- Source :
- Journal of Thrombosis and Haemostasis; January 2020, Vol. 18 Issue: 1 p36-43, 8p
- Publication Year :
- 2020
-
Abstract
- Recombinant porcine factor VIII (rpFVIII, OBI‐1, susoctocog alfa) is used for the treatment of acute bleeds in patients with acquired hemophilia A (AHA). Inhibitors in AHA can sometimes cross‐react with rpFVIII.
Details
- Language :
- English
- ISSN :
- 15387933 and 15387836
- Volume :
- 18
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Journal of Thrombosis and Haemostasis
- Publication Type :
- Periodical
- Accession number :
- ejs62069447
- Full Text :
- https://doi.org/10.1111/jth.14618